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The induction and maintenance of T cell memory
is critical to the success of vaccines. A recently
described subset of memory CD8+ T cells defined
by intermediate expression of the chemokine recep-
tor CX3CR1 was shown to have self-renewal, prolif-
erative, and tissue-surveillance properties relevant
to vaccine-induced memory. We tracked these cells
when memory is sustained at high levels: memory
inflation induced by cytomegalovirus (CMV) and
adenovirus-vectored vaccines. In mice, both CMV
and vaccine-induced inflationary T cells showed sus-
tained high levels of CX3R1int cells exhibiting an
effector-memory phenotype, characteristic of infla-
tionary pools, in early memory. In humans, CX3CR1int
CD8+ T cells were strongly induced following adeno-
virus-vectored vaccination for hepatitis C virus (HCV)
(ChAd3-NSmut) and during natural CMV infection
and were associated with a memory phenotype
similar to that in mice. These data indicate that
CX3CR1int cells form an important component of
the memory pool in response to persistent viruses
and vaccines in both mice and humans.
INTRODUCTION
During an infection, naive T cells become activated and proliferate
upon recognition of cognate antigen, giving rise to effector sub-
sets. While effector T cell populations contract following control
of infection, a fraction persists as diverse long-lived memory T
(Tmem) cells. Tmem cells are heterogeneous subsets defined by
homing receptor expression and tissue localization. Traditionally,
two major Tmem subsets in blood were defined based on
expression of lymph node homing receptors CCR7 and CD62L,
denoting CCR7+/CD62L+ central-memory (TCM) cells, with the
capacity to migrate to lymphoid tissues, and CCR7/CD62L
effector-memory (TEM) cells, which are able to migrate to periph-
eral tissues (Sallustoet al., 1999). TCMcells havesuperior ability to
produce interleukin-2 (IL-2), proliferate and persist within the host,768 Cell Reports 23, 768–782, April 17, 2018 ª 2018 The Author(s).
This is an open access article under the CC BY license (http://creativeand become the predominant memory CD8+ T cell subset over
time (Wherry et al., 2003). By comparison, TEM cells are more
cytotoxic, migrate to diverse peripheral tissues sites, and until
recently, were thought to be the dominant subset performing
tissue surveillance (Sallusto et al., 1999). Recently identified,
non-migratory tissue-resident memory (TRM) cells, a third Tmem
subset, are localized in diverse tissue sites andmediate local pro-
tective immune responses (Mueller and Mackay, 2016).
Gerlach et al. (2016) identified a fourth Tmemsubset, peripheral
memory (TPM) cells, which are defined by intermediate levels of
expression of the chemokine receptor CX3CR1 (Fractalkine re-
ceptor). Using Cx3cr1+/gfp+ reporter mice infected with lympho-
cytic choriomeningitis virus (LCMV) or vaccinia virus, Gerlach
et al. (2016) showed that CX3CR1int TPM cells, rather than
CX3CR1hi TEM cells, are the predominant migratory Tmem cells
that survey peripheral tissues. In addition, CX3CR1int TPM cells
have superior homeostatic proliferation capacity compared with
other Tmem subsets and not only self-renew but also contribute
to the expanding CX3CR1neg TCM pool. The identification of
CX3CR1int TPM cells necessitates re-examination of the roles
that different CD8+ T cell subsets play in immunosurveillance
and protection against re-infection to a variety of pathogens.
CD8+ T cells are crucial for the immune response to infections
and cancer, and eliciting large and persistent effector T cell pop-
ulations has been the focus of vaccine development. The role of
CX3CR1int TPM cells in the generation andmaintenance of robust
vaccine-derived Tmem populations is yet to be fully explored.
Cytomegalovirus (CMV) and adenoviral vectors induce an
expanded, sustained TEM CD8+ T cell response to specific epi-
topes, termed memory inflation, leading to interest in these cells
as vaccinemodalities (Klenerman andOxenius, 2016). Inflationary
T cells maintain effector function and ability to proliferate but lack
features of T cell exhaustion (Klenerman and Oxenius, 2016).
CMV infection in mice and humans (MCMV and HCMV, respec-
tively) can lead to single-specificity inflationary T cells comprising
of up to 20% of the circulating T cell pool, which develop in
parallel with conventional non-inflating TCM responses to many
epitopes (Karrer et al., 2003). Preclinical models of HIV vaccines
using simian CMV vectors show promise and generate atypical
major histocompatibility complex (MHC) class II and human
leukocyte antigen (HLA)-E-restricted CD8+ T cell responses
(Hansen et al., 2011, 2016). Adenoviral vector-induced T cellcommons.org/licenses/by/4.0/).
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responses in a murine model using a recombinant replication-
deficient human adenovirus 5 (HuAd5) vector expressing b-galac-
tosidase (Ad-lacZ) led to memory inflation of T cell responses to
one of two immunodominant epitopes (Bolinger et al., 2013). Clin-
ical studies of replication-deficient adenoviral vectors have shown
potency in generation of antiviral T cell pools with features that
overlap with those of inflated populations in MCMV and HCMV
infection (Bolinger et al., 2015; Swadling et al., 2014).
Understanding induction and maintenance of robust T cell
memory is important for thedevelopment ofCD8+T cells vaccines
that aim to induce large numbers of memory CD8+ T cells of a
favorable phenotype able to provide optimal protection against
complex pathogens.However, the phenotype of thememory cells
that maintain large CD8+ T memory pools remains incompletely
defined (Klenerman and Oxenius, 2016). The identification of
CX3CR1int TPMcells with enhanced self-renewal and proliferative
properties (Gerlach et al., 2016) prompted us to explore the role of
CX3CR1int TPM cells in the generation and maintenance of
inflating and conventional Tmem populations induced by persis-
tent infection and non-replicative adenoviral vectors in mice and
humans. In mouse models, both CMV and vaccine-induced infla-
tionary CD8+ T cells showed high frequencies of CX3CR1int cells
exhibitingaTEMphenotypebutdelayeddifferentiation, in theearly
memory phase, compared to conventional CD8+ T cell memory.
CX3CR1 expression was not required for memory inflation,
although blunted memory cell frequencies and differentiation
were seen in Cx3cr1gfp+/gfp+ mice following vaccination. As in
mice, humans receiving an adenovirus-vectored vaccine for hep-
atitis C virus (HCV) (ChAd3-NSmut) had CX3CR1int CD8+ T cells
that were strongly induced and maintained in the long term and
were associated with a TEM phenotype. Similar observations
were made in natural HCMV infection. These data indicate that
CX3CR1int memory cells form a substantial component of the
memory pool in response to persistent viruses and vaccines in
both mice and humans.
RESULTS
MCMV Infection Induces Three Subsets Based on
CX3CR1Expression Levels inConventional and Inflating
Virus-Specific CD8+ Tmem Cells
To characterize CX3CR1 expression on CD8+ Tmem cells in
persistent viral infection, we first analyzed the well-characterizedFigure 1. Persistent Infection with Murine CMV Induces Three Distinct
flationary CD8+ T Cell Memory
Cx3cr1+/gfp+ mice were infected i.v. with 106 PFU (full dose) or 2,000 PFU (low do
(black label) were assessed by M45-tetramer staining, and inflationary memory
blue; hi, green. Coloring is consistent for all panels.
(A) Composite fluorescence-activated cell sorting (FACS) plots (n = 2–5) of M45-
tetramer+ CD8+ T cells (right) early (25 or 30 days post-infection [dpi]) and late
indicated (n = 2–5).
(B) Mean (±SD) CX3CR1 subsets of M45- and M38-tetramer+ CD8+ T cells (n = 2
(C and D) Expression of surface markers CD62L, CD27, and CD127 by CX3CR1
(C) Composite FACS plots (n = 3) from left to right (L to R) of CD62L, CD27, andCD
expression for each CX3CR1 subset (n = 3).
(D) Mean (±SD) expression (L to R) of CD62L, CD27, and CD127 by CX3CR1 subs
2–5 mice from 2–4 independent time course experiments.
See also Figures S1 and S2.
770 Cell Reports 23, 768–782, April 17, 2018model of MCMV infection. Intravenous (i.v.) infection of C57BL/6
mice with 106 plaque-forming unit (PFU) MCMV results in two
distinct CD8+ T cell memory (Tmem) responses, the conventional
(contracting) and the expanded (inflating) CD8+ T cell response in
blood (Figure S1) (Bolinger et al., 2015). Conventional memory re-
sponses in the MCMV model provide an internal control for anal-
ysis of the inflating memory response, because variables such
as viral replication and antigen persistence are identical.
CX3CR1 expression levels distinguished three virus-specific
CD8+ Tmem subsets (CX3CR1neg, CX3CR1int, and CX3CR1hi) in
both conventional (M45-tetramer+) and inflating (M38-tetramer+)
responses (Figures S2A–S2D; Table S3), while uninfected
C57BL/6 mice were devoid of CD8+ T cells expressing CX3CR1
(Figure S2A). To further characterize CX3CR1 expression, we
used Cx3cr1+/gfp+ reporter mice in which GFP was introduced
into the Cx3cr1 locus. Following i.v. injection of 106 PFU (high
dose) MCMV, three subsets based on CX3CR1 expression levels
were distinguished in conventional and inflating CD8+ Tmem re-
sponses in blood (Figure 1A). GFP-expressing CD8+ T cells were
absent from uninfected Cx3cr1+/gfp+ mice (Figure S2A) (Bo¨ttcher
et al., 2015; Gerlach et al., 2016). The frequency distribution of
MCMV-specific CX3CR1int and CX3CR1hi Tmem cells differed in
C57BL/6 mice compared toCx3cr1+/gfp+mice (Figure S2C), likely
reflecting the transient surfaceexpressionofCX3CR1onC57BL/6
mice and the sustained fluorescence of GFP (half-life > 24 hr),
which is unaffected by CX3CR1 internalization (Jung et al., 2000).
During persistent MCMV infection, conventional Tmem cells
maintained substantial frequencies of CX3CR1neg cells (Figures
1A and 1B). Conventional Tmem populations maintained high
mean frequencies of CX3CR1int cells (40%–47%) in the early
memory phase (21–49 days post-infection [dpi]) before
CX3CR1neg and CX3CR1hi cells (58% and 51%, respectively)
become more frequent in the late memory phase (R50 dpi) (Fig-
ure 1B). Frequencies of CX3CR1int Tmem cells following acute
viral infection are markedly lower (15%) (Gerlach et al., 2016).
To address whether the infective dose influences CX3CR1
expression, we assessed CX3CR1 expression in Cx3cr1+/gfp+
mice infected i.v. with 2,000 PFU (low dose) MCMV (Figures 1A
and 1B). Again, conventional Tmem populations maintained
high mean frequencies of CX3CR1int cells (24%–44%), and
Tmem switched to predominantly CX3CR1neg cells at later mem-
ory time points, in keeping with conventional memory responses
following acute viral infection (Gerlach et al., 2016).Populations Based on CX3CR1 Expression in Conventional and In-
se) MCMV, and blood was serially sampled. Conventional memory responses
responses (pink label) were assessed by M38-tetramer staining. neg, red; int,
and M38-tetramer staining of live lymphocytes (left) and CX3CR1 subsets of
(69 or 90 dpi). Mean tetramer+ CD8+ T cells and mean CX3CR1 subsets are
–9).
subset on M45- and M38-tetramer+ CD8+ T cells.
127 expression onM45- andM38-tetramer+ CD8+ T cells 47 dpi, showingmean
et on M45- and M38-tetramer+ CD8+ T cells (n = 2–3). Data are compiled from
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Figure 2. Immunization with Replication-Deficient Adenovirus Encoding MCMV Epitopes Induces Three Distinct Populations Based on
CX3CR1 Expression in Conventional and Inflationary Memory CD8+ T Cells
Cx3cr1+/gfp+ mice were immunized i.v. with 2 3 109 PFU of a recombinant replication-deficient HuAd5 vector expressing lacZ (Ad-lacZ), and blood was serially
sampled. Conventional memory responses (black label) were assessed by I8V-tetramer staining, and inflationary memory responses (pink label) were assessed
D8V-tetramer staining. Coloring is consistent for all panels.
(legend continued on next page)
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In comparison, inflationary Tmemcells during persistentMCMV
infection were nearly all CX3CR1 positive (int and hi) (Figures 1A
and 1B), consistent with previous reports (Bolinger et al., 2015).
Similar to the conventional Tmem response, inflationary Tmem
populationsmaintained highmean frequencies of CX3CR1int cells
(50%–62%) in the early memory phase (21–49 dpi) before switch-
ing to predominantly CX3CR1hi cells (90%) in the late memory
phase (R50 dpi) (Figure 1B). Following infection with low-dose
MCMV, inflationary Tmem populations again maintained high
mean frequencies of CX3CR1int cells (67%–75%); however,
Tmem did not switch to CX3CR1hi cells at later time points (Fig-
ures 1A and 1B). Altogether, these results suggested that low-
level viral replication supports CX3CR1int Tmem cells, while
high-level viral replication drives CX3CR1hi Tmem cells in both
conventional and inflating Tmem populations.
CX3CR1int CD8+ T Cells Retain a TEM Phenotype during
Memory Inflation
We next asked whether tissue homing, activation state, or main-
tenance profile differed amongCX3CR1 subsets in Tmemcells in
blood following MCMV infection. We examined lymph node
homing based on L-selectin (CD62L), differentiation based on
CD27, and the homeostatic cytokine interleukin-7 receptor
(IL-7R) CD127. CD27 is upregulated during the first days after
T cell receptor activation and downregulated during T cell
effector differentiation (Hintzen et al., 1993). CD127 expression
is downregulated by activated effector T cells (Kiazyk and
Fowke, 2008) and on inflationary CD8+ T cells following response
to IL-7 (Bolinger et al., 2013). Previous study of Tmem cells using
acute viral infection models (Gerlach et al., 2016) have described
CX3CR1neg cells as TCM (CD62L+, CD27+, CD127+), CX3CR1hi
cells as TEM (CD62L, CD27, CD127), and CX3CR1int cells
as having phenotypic features more similar to CX3CR1neg cells
(CD62L+/, CD27+, CD127+). In contrast, persistent MCMV
infection led to a CX3CR1int phenotype that closely resembled
TEM CX3CR1hi cells in both conventional and inflating Tmem
populations in Cx3cr1+/gfp+ (Figures 1C and 1D) and wild-type
(WT) C57BL/6 mice (Figures S2E and S2F). CD62L expression
remained low on CX3CR1int cells regardless of infective dose
(Figure 1D; Figure S2I), and CD27 and CD127 expression on
CX3CR1int cells decreased over time (Figures 1C and 1D; Fig-
ures S2E and S2F). Our results suggest that in persistent
MCMV infection, the overall phenotype of CX3CR1int cells is
that of an TEM pool, reflecting the well-described features asso-
ciated with this setting of persistent infection and antigen expo-
sure. Nevertheless, even within the TEM pool, they showed
some delayed differentiation compared to CXC3R1hi counter-
parts (Figure 1D; Figure S2F).(A) Composite FACS plots (n = 4) of I8V- and D8V-tetramer staining (left) and CX3
T cells and mean CX3CR1 subsets are indicated (n = 4).
(B) Mean (±SD) CX3CR1 subsets of I8V- and D8V-tetramer+ CD8+ T cells.
(C and D) Expression of surface markers CD62L, CD27, and CD127 by CX3CR1
(C) Composite FACS plots (n = 5) (L to R) of CD62L, CD27, and CD127 expressio
mean expression for each CX3CR1 subset (n = 5).
(D) Mean (±SD) CX3CR1 subsets expressing CD62L (top left), CD27 (top right), a
(E) Ki67 expression by CX3CR1 subset in I8V- and D8V-tetramer+ CD8+ T cells is
independent time course experiments.
See also Figures S1 and S3.
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To further explore the contribution of viral replication and/or an-
tigen persistence to the distribution and phenotype of CX3CR1
Tmem subsets, we examined the qualities of vaccine-induced
responses following administration of a recombinant replica-
tion-deficient Ad-lacZ (Bolinger et al., 2013). Ad-lacZ immuniza-
tion induces two distinct pathways for memory: a typical con-
tracting response to a one epitope (I8V) and an inflating
response to second epitope (D8V), which is analogous to con-
ventional (M45) and inflating (M38) responses to MCMV infection
(Bolinger et al., 2013). i.v. immunization of Cx3cr1+/gfp+ and WT
C57BL/6 mice with 2 3 109 PFU Ad-lacZ resulted in two CD8+
Tmem responses, the conventional (contracting, I8V-tetramer+)
and the expanded (inflationary, D8V-tetramer+) CD8+ T cell
response in blood (Figure 2A; Figures S1 and S3A). CX3CR1
expression levels distinguished three CD8+ Tmem subsets
(neg, int, and hi) (Figure 2A; Figure S3A), as withMCMV infection.
Similar to MCMV infection, conventional I8V-tetramer+ cells
maintained increasing frequencies of CX3CR1neg cells, and
inflating D8V-tetramer+ cells were nearly all CX3CR1 positive
(int and hi) (Figures 2A and 2B; Figure S3B), consistent with
previous reports (Bolinger et al., 2015). In the early memory
phase, more conventional I8V-tetramer+ cells were CX3CR1
positive compared to M45-tetramer cells, which may reflect
continued presentation of I8V antigen in the Ad-lacZ model.
Similar to MCMV infection, Ad-lacZ-derived conventional and
inflating Tmem populations contained significant frequencies
of CX3CR1int cells (ranges 22%–86% and 21%–94%, respec-
tively) during the early memory phase (21–89 dpi) (Figure 2B),
which had a TEMphenotype (CD62L, CD27, CD127) (Figures
2C and 2D). During the late memory phase (>90 dpi), CX3CR1neg
cells dominated conventional I8V-tetramer+ responses (Fig-
ure 2B) and resembled TCM (CD62L+, CD27+, CD127+), while
late inflationary D8V-tetramer+ T cells were mostly CX3CR1hi
and resembled TEM (CD62L, CD27, CD127) (Figures 2C
and 2D). As reported previously (Gerlach et al., 2016), CX3CR1int
cells divided more intensively than CX3CR1neg and CX3CR1hi
cells, as measured by Ki67 staining, in both conventional
and inflating memory populations (Figure 2E). A similar pheno-
type of CX3CR1int cells in Ad-lacZ-derived conventional and
inflating populations was observed in C57BL/6WTmice (Figures
S3A–S3D).
CD8+ T Cells in Tissues Are CX3CR1hi in the Setting
of Persistent Antigen
We next examined CX3CR1 expression in MCMV and Ad-
lacZ Tmem responses in tissues (spleen, liver, and lung) ofCR1 subsets of tetramer+ CD8+ T cells (right) 30 dpi. Mean live tetramer+ CD8+
subset on I8V- and D8V-tetramer+ CD8+ T cells.
n by CX3CR1 subset in I8V- and D8V-tetramer+ CD8+ T cells 75 dpi, showing
nd CD127 (bottom left) in I8V- and D8V-tetramer+ CD8+ T cells (n = 3–13).
olated from spleen (n = 2) 44 dpi. Data are compiled from 2–19 mice from 2–4
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Figure 3. Inflationary Memory T Cells in Tis-
sues Express High Levels of CX3CR1
followingMCMV Infection or Ad-lacZ Immu-
nization
CX3CR1 subset distribution of conventional and
inflationary memory CD8+ T cells responses was
assessed in blood (BLD), spleen (SPL), liver (LIV),
and lung following MCMV or Ad-lacZ infection or
immunization.
(A) Cx3cr1+/gfp+ mice were infected i.v. with 106
PFU MCMV (solid symbols) or 2,000 PFU MCMV
(open symbols). CX3CR1 subset frequencies for
M45- and M38-tetramer+ CD8+ T cells are shown.
(B) Cx3cr1+/gfp+mice were immunized i.v. with 23
109 PFU Ad-lacZ. CX3CR1 subset frequencies
and means for I8V- and D8V-tetramer+ CD8+
T cells are shown.
(C–E) Live lymphocytes from SPL, LIV, lung, and
gut intraepithelium (IEL) labeled by (intravascular,
IV) or protected from (extravascular, EV) i.v. anti-
Thy1 antibodies in C57BL/6 (WT) mice 39 or 198
dpi with Ad-lacZ (n = 6 for SPL, LIV, and lung; n = 1
for IEL).
(C) Representative FACS plots showing mean EV
(right number) and IV (left number) CD8+ T cells.
(D) Individual and mean EV I8V- and D8V-
tetramer+ CD8+ T cells.
(E) CX3CR1 subset frequencies and means of EV
I8V- and D8V-tetramer+ CD8+ T cells.
Statistically significant differences (SSDs) were
determined by t test and corrected for multiple
comparisons (Holm-Sidak). *p = 0.05 to 0.011,
**p = 0.01 to 0. 001, ***p < 0.001. Data are
compiled from 3–4 independent experiments. See
also Figures S2 and S3.Cx3cr1+/gfp+ and C57BL/6 WT mice (Figure 3; Figures S2G, S2H,
S3E, and S3F). The spleen, liver, and lungs are sites of viral ampli-
fication inacuteMCMV infectionandcontainhigherviral titers than
the blood (Vliegen et al., 2003). We hypothesized that CX3CR1hi
cells would bemore prevalent at these tissue sites with high levels
of viral replication.CX3CR1subsetdistribution in spleen, liver, and
lungwasdistinct from that in bloodat similar timepoints,with con-
ventional tissue Tmem cells containing a mix of CX3CR1neg and
CX3CR1hi cells and inflating tissue Tmem cells largely consisting
of CX3CR1hi cells (Figures 1B and 3A; Figure S2G). CX3CR1int
cellswere largely absent from tissueTmempopulations; however,Ceinfection with low-dose MCMV resulted in
some CX3CR1int cells in the inflating pop-
ulation (Figure 3A).
As in MCMV infection, following Ad-
lacZ vaccination, CX3CR1int conventional
and inflating Tmem cells were largely ab-
sent from tissues yet were present in the
blood at similar time points (Figure 3B).
Using in vivo antibody labeling to identify
extravascular (i.e., unlabeled by i.v. anti-
body) Tmem cells (Figure 3C), conven-
tional tissue Tmem cells were mostly
CX3CR1neg, as reported previously (Ger-
lach et al., 2016), and inflating tissueTmem cells were mostly CX3CR1hi (Figures 3D and 3E).
Most I8V- and D8V-tetramer+ cells in the liver were accessible
to the circulation (i.v.) (Figures 3C and 3D) yet had high ex-
pression (82%–98%, n = 3) of the intracellular adhesion mole-
cule 1 (ICAM-1) ligand leukocyte function-associated antigen 1
(LFA-1) (Figure S3F), regardless of CX3CR1 subset. LFA-1
expression has been shown to allow liver-resident Tmem to pa-
trol and remain in hepatic sinusoids (McNamara et al., 2017). As
has been reported (Smith et al., 2015), lung inflationary Tmem
cells (M38- and D8V-tetramer+) did not express the tissue-resi-
dent markers CD69 and CD103 (Figure S2H). Ad-lacZ DNAll Reports 23, 768–782, April 17, 2018 773
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Figure 4. CX3CR1 Is Required for Optimal Inflating Responses following Ad-lacZ Immunization
Cx3cr1gfp+/gfp+ mice were infected i.v. with 106 PFU MCMV or 2 3 109 PFU Ad-lacZ, and blood was serially sampled.
(A) Composite FACS plots of M45- and M38-tetramer staining (left, n = 4) and I8V- and D8V-tetramer staining (right, n = 6) of live lymphocytes and CX3CR1
subsets of tetramer+ CD8+ T cells. Mean tetramer+ CD8+ T cells and mean CX3CR1 subsets are indicated.
(B) Mean (±SD) M45- and M38-tetramer+ CD8+ T cells in blood from Cx3cr1+/gfp+ mice (orange half-filled square, n = 2–3) and Cx3cr1gfp+/gfp+ mice (purple-filled
square, n = 3–4).
(C) Mean (±SD) I8V- and D8V-tetramer+ CD8+ T cells in blood from Cx3cr1+/gfp+ mice (n = 3–19) and Cx3cr1gfp+/gfp+ mice (n = 3–15).
(D) Mean (±SD) I8V- and D8V-tetramer+ CD8+ T cells in spleen (SPL), liver (LIV), and lung from Cx3cr1gfp+/gfp+ mice (n = 4–5) and Cx3cr1gfp+/gfp+ mice (n = 7).
(E) Mean (±SD) CX3CR1 subsets of I8V- and D8V-tetramer+ CD8+ T cells in blood of Cx3cr1gfp+/gfp+ mice (n = 3–15).
(F) CX3CR1 subset frequencies and mean of I8V- and D8V-tetramer+ CD8+ T cells in spleen (SPL), liver (LIV), and lung from Cx3cr1gfp+/gfp+ mice.
(legend continued on next page)
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and RNA can be isolated from spleen, liver, and lung at day 100
post-immunization (Bolinger et al., 2013), suggesting that vac-
cine antigen may be present in tissues a long time after immuni-
zation. Altogether, the similarities of CX3CR1 subset distribution
and phenotype between persistentMCMV infection and immuni-
zation with a non-replicative adenoviral vector support the role of
antigen persistence rather than viral replication in determining
the expression and phenotype of CX3CR1 subsets on Tmem
cells.
CX3CR1 Is Required for Optimal Inflating T Cell Memory
Responses following Ad-lacZ Immunization
The previous study has indicated that CX3CR1 is not required for
antigen recognition or effector differentiation following acute
viral infection (Gerlach et al., 2016). We next explored whether
CX3CR1 is required for Tmem development in persistent
MCMV infection and/or immunization with Ad-lacZ. We used
Cx3cr1gfp+/gfp+ mice in which GFP was knocked in to both
Cx3cr1 loci; therefore, functional CX3CR1 protein is not ex-
pressed. Mice were infected with high-dose MCMV, low-dose
MCMV, or Ad-lacZ, as described previously. Cx3cr1gfp+/gfp+
mice generated robust conventional and inflating Tmem re-
sponses in blood (Figures 4A and 4B) and tissues (Figure S4B)
following high- and low-dose MCMV infection with similar
CX3CR1 subset distribution to that of Cx3cr1+/gfp+ mice (Figures
S4A and S4C). In contrast, CX3CR1 was required for optimal
magnitude of inflating (D8V+) Tmem responses, but not conven-
tional (I8V+) Tmem responses, following Ad-lacZ immunization in
blood (Figure 4C) and tissues (Figure 4D). Further characteriza-
tion of D8V+ cells from Cx3cr1gfp+/gfp+ mice revealed a
CX3CR1 subset distribution similar to that for Cx3cr1+/gfp+
mice in blood (Figures 2B and 4E) and tissues (Figures 3B and
4F) but increased CD27 (Figure 4G) and decreased KLRG1 (Fig-
ure 4H) expression over time in CX3CR1int subsets. CX3CR1-ex-
pressing macrophages are thought to be involved in the spread
of MCMV (Daley-Bauer et al., 2014); however, because differ-
ences were not observed in the conventional memory (M45-
and I8V-tetramer+) populations, which act as an internal control
(Figures 4A–4F; Figure S4), viral spread inCx3cr1gfp+/gfp+mice is
likely to be preserved. No differences were observed in the num-
ber of CD8+ T cells in tissues between Cx3cr1+/gfp+ and
Cx3cr1gfp+/gfp+ mice, indicating that T cell localization remains
intact (Table S1). These results suggest that CX3CR1 is not
required for memory inflation but is required for optimal re-
sponses and effector differentiation of inflating vaccine-derived
Tmem cells.
Distribution and Phenotype of ThreeCX3CR1 Subsets in
Human CD8+ T Cells
We next addressed whether such changes in CX3CR1 expres-
sion and phenotype can be observed in human memory pools
induced by CMV and adenoviral vectors. There are limited
human data describing the distribution and phenotype of(G and H) Expression of CD27 (G) and KLRG1 (H) by CX3CR1 subset in D8V-tetram
120 dpi.
Shown are individual values and mean. SSDs were determined by t test and corre
001, ***p < 0.001. Data are compiled from 3–5 independent experiments. See alCX3CR1 subsets in polyclonal CD8+ T cells. To address this
knowledge gap, we first focused on whether CX3CR1 expres-
sion can distinguish three CD8+ Tmem cell subsets in humans
by analyzing peripheral blood mononuclear cells from 13 volun-
teers aged 21–54 years (Table S2). Samples were collected as
part of adenoviral-vaccine studies (n = 10) or from healthy volun-
teers (n = 3). Polyclonal CD8+ T cell subset distribution and
CX3CR1 expression did not differ during the vaccine study,
and the end-of-study (EOS) sample was used for analysis.
CX3CR1 expression levels distinguished three CX3CR1
subsets (neg, int, and hi) on bulk CD8+ T cells (Figure 5A; Fig-
ure S5A). Delineation of CD8+ T cells into subsets based on
CD45RA and CCR7 expression (naive, CD45RA+/CCR7+; TCM,
CD45RA/CCR7+; TEM, CD45RA/CCR7; and terminal
effector [TEMRA], CD45RA+/CCR7), showed variation in the
CX3CR1 population distribution within each subset (Figures
5B–5D). TEM and TEMRA cells had comparative frequencies
of CX3CR1int cells (17% and 19%, respectively) (Figure 5D),
while CX3CR1neg were more prevalent in TEM cells (i.e.,
CX3CR1neg > hi > int) and CX3CR1hi cells were more prevalent
in TEMRA cells (i.e., CX3CR1hi > neg = int). Naive and TCM cells
were mostly CX3CR1neg, with some CX3CR1int cells in the TCM
subset (Figures 5B–5D). We next analyzed the phenotypic
markers CD27 and CD127 and the transcription factors T-bet
and Eomes (Figures 5E and 5F). Most TEM and TEMRA
CX3CR1int cells had features of effector memory and antigen-
mediated activation (CD27, CD127, T-bet+), which were
more pronounced in the TEMRA population. Overall, the pheno-
type of CX3CR1int cells represented a mid-point between the
CX3CR1neg and the CX3CR1hi populations, consistent with
CD8+ T cell differentiation being a continuum (Figure 7F) (Wong
et al., 2016).
Human Adenoviral Vaccine and Persistent CMV
Infection Induce CX3CR1int Antigen-Specific CD8+
Tmem Cells
To assess how CX3CR1 subsets on Tmem cells relate to persis-
tent infection and adenoviral-vaccine-induced responses in
humans, we analyzed (1) CD8+ T cells primed using a chim-
panzee adenovirus strategy (ChAd3-NSmut), specific for domi-
nant HCV epitopes from NS3 (NS395, HLA-A2 restricted, and
NS3103, HLA-A1 restricted) (Swadling et al., 2014), and (2)
CMV-specific CD8+ T cells.
CX3CR1 expression was assessed in adenoviral vaccine-
induced CD8+ T cells in blood obtained from 9 volunteers,
aged 21–54 years (Table S2). All volunteers received a priming
regimen of ChAd3-NSmut (53 108–2.53 1010 viral particles) en-
coding the NS3, NS4, NS5A, and NS5B proteins of HCV geno-
type 1b (Figure S5B) (Swadling et al., 2014). A subset of 5 volun-
teers also received a boost with a modified vaccinia Ankara
(MVA)-NSmut (2 3 107–2 3 108 PFU) vector encoding the
same HCV genotype 1b proteins 8 weeks later (Figure S5;
Table S2). Blood samples were taken at peak response afterer+ CD8+ T cells inCx3cr1+/gfp+ (HET, n = 3) andCx3cr1gfp+/gfp+ (KI, n = 5) mice
cted for multiple comparisons (Holm-Sidak). *p = 0.05 to 0.011, **p = 0.01 to 0.
so Figure S4.
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ChAd3-NSmut prime (trial weeks [TW] 2–4, prime), peak res-
ponse after MVA-NSmut boost (TW9, boost), and at end of study
(EOS) (TW16–TW32). Peak vaccine responses were determined
by ELISpot as described previously (Swadling et al., 2014). Vac-
cine-derived CD8+ T cells were assessed by staining with
HLA-A2 pentamers containing an NS3 epitope (A2-NS3 pen-
tamer) (Table S3). All volunteers had detectable A2-NS3 pen-
tamer+ T cells (defined as R0.10% CD8+ T cells) after priming,
which increased in frequency following MVA boost and con-
tracted by EOS (Figure 6A), as reported previously (Swadling
et al., 2014). No differences in NS3 pentamer+ CX3CR1 subsets
were observed at EOS in those that received MVA boost and
those that did not (Figure S5C), and both groups were combined
for the EOS analysis. NS3 pentamer+ T cells were predominantly
TEM cells following prime and boost immunization, with TEMRA
cells becoming more prevalent by EOS (Figure 6B) (Swadling
et al., 2014). CX3CR1 expression and phenotype were assessed
in total NS3 pentamer+ CD8+ T cells because of the low number
of NS3 pentamer+ T cells analyzed per memory subset. CX3CR1
expression levels distinguished three NS3 pentamer+ T cell CD8+
T subsets (Figure 6A), resembling the CX3CR1 subset distribu-
tion pattern observed in polyclonal CD8+ TEM and TEMRA cells
(Figure 5C). At all time points, CX3CR1int NS3 pentamer+ cells
were detected at stable mean frequency (range 22%–37%).
CX3CR1hi NS3 pentamer+ cells were more prevalent than
CX3CR1int NS3 pentamer+ cells following prime, and no differ-
ences in CX3CR1 subset distribution were observed at other
time points. Analysis of phenotypic markers CD27 and CD127
and transcription factors T-bet and Eomes (Figures 6D and 6E)
shows a TEM phenotype (T-bet+) in all CX3CR1 subsets after
boost and, to a lesser extent, after prime. By EOS, the phenotype
of NS3 pentamer+ CX3CR1 subsets resembled polyclonal TEM
and TEMRA populations. These results indicate that human
adenovector vaccination can induce and sustain all three
CX3CR1 subsets with a similar phenotype to polyclonal CD8+
TEM cells. A persistent mixed memory population of TEM,
TCM, and TEMRA cells is indicative of a functional memory
response induced by adenovectors and is characterized by
increasing CD127 expression, T-bet retention, and reducing
Eomes expression (Swadling et al., 2014).
We next assessed CX3CR1 expression in CMV-specific CD8+
T cells in blood obtained from 6 volunteers, aged 21–54 years
(Table S2). Three volunteers also received the adenovirus vac-Figure 5. Three Distinct Human CD8+ T Cell Populations Based on CX
CD8+ T cell expression of CX3CR1 was assessed in blood obtained from 13 volu
(A) Composite FACS plot (n = 5) of CX3CR1 expression gated on live CD3+ lympho
(n = 13). Individual CX3CR1 subset frequencies are shown on the right (n = 13).
(B) Left: CD8+ T cell subsets defined as CD45RA+/CCR7+ (naive), CD45RA/CC
CD45RA+/CCR7 (terminal effector; TEMRA). Right: composite FACS plots (n = 5)
subset means are indicated (n = 13).
(C) Individual CX3CR1 subset frequencies in naive, TCM, TEM, and TEMRA CD8
(D) Mean (±SD) CX3CR1 subsets in naive, TCM, TEM, and TEMRA CD8+ T cells
(E and F) CX3CR1 subset expression of cell surface markers (CD27 and CD127)
(E) Composite FACS plots (n = 5) (L to R) of CD27, CD127, T-bet, and Eomes ex
expression for each CX3CR1 subset is indicated (n = 13).
(F) Individual and mean CX3CR1 subset expression (L to R) of CD27, CD127, T-
SSDs were determined by two-way ANOVA and corrected for multiple compariso
compiled from a single experiment. See also Figure S5.cine, and their EOS sample was used for the CMV analysis (no
difference was observed in CMV tetramer+ T cells and
CX3CR1 expression at any trial time point) (data not shown).
CMV-specific T cells were identified by staining with HLA-
matched tetramers or pentamers containing immunodominant
CMV epitopes (Table S3). CMV tetramer+ CD8 T cells were
mostly CX3CR1int (26%) or CX3CR1hi (61%) (Figures 7A–7C).
Analysis of phenotypic markers CD27 and CD127 and transcrip-
tion factors T-bet and Eomes (Figures 7D and 7E) revealed heter-
ogenous expression patterns that were not related to magnitude
of CMV tetramer+ response or dominance of TEM or TEMRA
response. These results suggest that CX3CR1 expression and
phenotype on CMV-specific T cells form a dynamic process
responsive to an individuals’ CMV latency and reactivation
events.
DISCUSSION
The induction and maintenance of robust CD8+ T cell memory
are important for the control of persistent infection and critical
to the success of vaccines against infections and cancers. The
identification of CX3CR1int TPM cells, a Tmem subset with
self-renewal, proliferative, memory pool maintenance, and tis-
sue-surveying properties, prompted us to hypothesize that
CX3CR1int TPM cells underlie the ability of CMV and adenoviral
vectors to induce and sustain large inflationary CD8+ Tmem re-
sponses. By profiling CX3CR1 expression on MCMV- and
adenovirus vaccine-specific memory CD8+ T cells, we identified
high levels of inflationary CX3R1int cells in the early memory
phase compared to conventional CD8+ T cell memory. The
CX3CR1int memory pool showed a TEM phenotype character-
istic of inflationary pools but showed delayed differentiation. In
humans, administration of an adenovirus-vectored vaccine for
HCV induced andmaintained CX3CR1int CD8+ T cell populations
associated with a memory phenotype similar to that in mice and
in natural HCMV infection.
Using Cx3cr1+/gfp+ reporter mice, Gerlach et al. (2016) re-
ported that approximately 15%of circulating conventional mem-
ory cells were CX3CR1int following acute viral infection (LCMV
and vesicular stomatitis virus [VSV]) and that CX3CR1int dis-
played some features closer to CX3CR1 neg TCM cells (similar
proliferation, CD27+, and CD127+) while other functional abilities
(IL-2 production, cytotoxicity, and lymph node [LN] homing) were3CR1 Expression
nteers.
cytes (left) withmean CX3CR1 subset frequency of CD8+CD3+ T cells indicated
R7+ (central memory; TCM), CD45RA/CCR7 (effector memory; TEM), and
of CX3CR1 expression in naive, TCM, TEM, and TEMRACD8+ T cells. CX3CR1
+ T cells (n = 13).
(n = 13).
and transcription factors (T-bet, Eomes) in CD8+ Tmem cells.
pression by CX3CR1 subsets on TCM, TEM, and TEMRA CD8+ T cells. Mean
bet, and Eomes in TCM, TEM, and TEMRA CD8+ T cells (n = 13).
ns (Holm-Sidak). *p = 0.05 to 0.011, **p = 0.01 to 0. 001, ***p < 0.001. Data are
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intermediate between CX3CR1hi TEM and CX3CR1neg TCM
cells. Also using Cx3cr1+/gfp+ reporter mice, we found that
even larger circulating populations of CX3CR1int cells are
induced and sustained in early inflating memory populations
following MCMV infection and Ad-lacZ immunization (range
21%–94%) and that inflating CX3CR1int cells have an effector
phenotype similar to that of their CX3CR1hi counterparts. By
comparison, CX3CR1int conventional memory populations
following MCMV infection and Ad-lacZ immunization (acting as
internal controls) shared similar features to the CX3CR1int con-
ventional memory cells described by Gerlach et al. (2016). Previ-
ous data have indicated that inflationary memory cells are
derived from the TCM pool (Smith et al., 2014). Our data suggest
that CX3CR1int cells, either derived from CX3CR1neg TCM or
self-renewing, contribute to stably maintaining the expanding
size and effector phenotype of the inflating memory population
(Figure 7F).
The initial sustained inflating CX3CR1int response observed in
our models is likely linked to low-level antigen persistence,
possibly by presentation on non-professional antigen-present-
ing cells (APCs). The current model for memory inflation involves
repetitive antigen presentation occurring on non-classical APCs,
potentially in the vascular endothelium or a non-hematopoietic
lymph node cell (Smith et al., 2014; Torti et al., 2011). To support
the role of low-level antigen persistence in inducing inflating
CX3CR1int cells, we found that (1) by reducing the infecting
dose of MCMV, circulating inflating CX3CR1int cells became
evenmore frequent; (2) in tissues where viral replication is ampli-
fied—and to lesser extent, when a reduced infecting dose was
used—CX3CR1hi inflating cells remained dominant; and (3)
inflating CX3CR1int Tmem cells have a TEM phenotype similar
to their CX3CR1hi inflating counterparts, suggesting ongoing an-
tigen exposure. Preservation of these characteristics in the
inflating memory pool induced by a non-replicating Ad-lacZ vac-
cine supports the notion that persistent antigen exposure, rather
than viral replication, promotes CX3CR1int expression and
phenotype. Conversely, the waning of the CX3CR1int population
at late time points may be due to a loss of antigen exposure.
Gerlach et al. (2016) describes CX3CR1int TPM cells as the
dominant Tmem subset surveying tissues, rather than CX3CR1hi
TEM cells, in a revision of a long-held paradigm. In our mouse
models where prolonged antigen exposure in tissues is a key
feature, CX3CR1int cells were largely absent from tissues, sug-Figure 6. Immunizationwith Replicative Defective Adenoviral Vectors In
T Cells in Humans
CX3CR1 expression was assessed in adenoviral vaccine-derived CD8+ T cell
after ChAd3-NSmut prime (trial weeks [TW] 2–4, prime, n = 9), peak response after
n = 9). Vaccine-derived CD8+ T cells were identified by staining with an HLA-A2
(A) Composite FACS plots of A2-NS3 pentamer staining (left) of live CD3+ lympho
pentamer+ CD8+ T cell frequency and mean CX3CR1 subset frequency are indic
(B) Pie chart showing mean CD8+ T cell subset distribution of A2-NS3 pentamer
(C) CX3CR1 subset frequency of A2-NS3 pentamer+ CD8+ T cells.
(D and E) CX3CR1 subset expression of cell surface markers (CD27 and CD127) a
(D) Composite FACS plots (L to R) of CD27, CD127, T-bet, and Eomes expression
is indicated.
(E) Individual values and mean CX3CR1 subset expression (L to R) of CD27, CD
SSDs were determined by one-way ANOVA (C) or two-way ANOVA (E) and corre
0.001, ***p < 0.001. Data are compiled from a single time course experiment. Segesting that inflating CX3CR1hi cells continue to play a role in
local tissue responses in settings of sustained antigen exposure.
Adenovirus-vectored HCV vaccination strongly induced and
maintained CX3CR1int CD8+ T cell populations (22%–34% of re-
sponses) with TEM characteristics, which overlapped with
CX3CR1int cells in natural HCMV infection and inflated popula-
tions in MCMV and adenovirus-vector models. Furthermore,
CMV- and adenovirus-vector-induced CX3CR1int Tmem cells
displayed the same TEM characteristics as those typically asso-
ciated with viral control (Swadling et al., 2014). Tmem cells ex-
pressing CX3CR1 are mostly absent from patients with chronic
HCV infection, and the few present have markers of cytotoxicity
(Bo¨ttcher et al., 2015). In combination with the previously re-
ported qualities of self-renewal, maintenance of memory pools,
and tissue surveillance, CX3CR1int cells may improve efficacy
and endurance of CD8+ T cells vaccine responses.
CX3CR1 appears to be an important marker for distinct T cell
memory subsets in mouse and human. We also explored the
requirement for CX3CR1 in the generation of memory inflation
in both MCMV and adenoviral models using Cx3cr1gfp+/gfp+
mice. We showed that CX3CR1 is not required for memory infla-
tion or conventional memory induction in the MCMV model.
However, in the Ad-lacZ model, some blunting of memory cell
frequencies and differentiation were seen following vaccination.
Thus, CX3CR1 does not overall play a non-redundant role in
memory formation, although the signal from the adenovirus-vec-
tor experiments suggests it may play a role in maintenance of in-
flated populations. This difference between the twomodels likely
relates to the continuous replication of MCMV and the additional
inflammatory responses. For example, MCMV-driven memory
inflation is relatively unaffected by lack of CD4+ T cell help,
whereas adenovirus-vector-induced memory is affected (Prov-
ine et al., 2014; Snyder et al., 2009).
Although the human and mouse data are broadly consistent,
we observed some differences. We distinguished three
CX3CR1 subsets (neg, int, and hi) on human polyclonal CD8+
Tmem cells. In contrast to mice, absence of CX3CR1 expression
did not define human TCM cells; 55% of TEM and 19% of
TEMRA cells were CX3CR1neg. CX3CR1int cells represented
approximately 20% of both TEM and TEMRA subsets and dis-
played features that were intermediate between CX3CR1hi and
CX3CR1neg cells within that CD8+ subset (i.e., differentiation,
CD127 [IL-7R] expression, and effector function). Overall, theduces Three Subsets Based onCX3CR1 Expression in CD8+Memory
s in blood obtained from 9 volunteers. Blood was taken at peak response
MVA-NSmut boost (TW9, boost, n = 5), and at end of study (TW16–TW32, EOS,
pentamer containing an HCV NS3 epitope (A2-NS3 pentamer).
cytes and CX3CR1 subsets of A2-NS3 pentamer+ CD8+ T cells. Mean A2-NS3
ated.
+ CD8+ T cells.
nd transcription factors (T-bet and Eomes) in A2-NS3 pentamer+ CD8+ T cells.
on A2-NS3 pentamer+ CD8+ T cells. Mean expression for each CX3CR1 subset
127, T-bet, and Eomes in A2-NS3 pentamer+ CD8+ T cells.
cted for multiple comparisons (Holm-Sidak). *p = 0.05 to 0.011, **p = 0.01 to
e also Figure S5.
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Figure 7. Natural Infection with Human CMV Induces Three CD8+ T Cell Subsets Based on CX3CR1 Expression
CX3CR1 expression was assessed in CMV-specific CD8+ T cells in blood obtained from 6 volunteers. CMV-specific CD8+ T cells were identified by tetramer
staining (Table S3).
(A) Composite FACS plots (n = 3) of A2-pp65 tetramer staining (left) of live CD3+ lymphocytes and CX3CR1 subsets (right) of A2-pp65 tetramer + CD8+ T cells.
Mean CMV tetramer+ CD8+ T cell frequency and mean CX3CR1 subset frequency are indicated (n = 6).
(legend continued on next page)
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transition from CX3CR1neg to CX3CR1hi via CX3CR1int maps
onto other T cell differentiation markers in both cases, although
the relationship is not exact and cells may transition from
one state to another via distinct routes, leading to the continuum
of differentiation observed using high-content cytometric ap-
proaches (Swadling et al., 2014; Wong et al., 2016).
Overall, we found that CX3CR1int memory cells form a sub-
stantial component of the memory pool in response to persistent
viruses and vaccines in both mouse and human. CX3R1int
inflating memory populations observed in the early memory
phase in mice are likely linked to low-level antigen presentation
on non-classical APCs, a feature that could be harnessed for
promoting CX3CR1int responses in humans. By identifying
CX3CR1int cells following adenovirus-vector vaccination, we
demonstrate the feasibility of targeting and tracking these cells
in CD8+ T cell vaccine strategies. The long-term self-renewal
properties of CX3CR1int TPM cells may be of relevance to the
longevity, maintained effector functions, and protective capacity
of these pools.
EXPERIMENTAL PROCEDURES
Animals
Mouse experiments were performed according to UKHomeOffice regulations
(PPL 30/3293 and 30/2744) and after approval by the University of Oxford
ethical review board. Mice were kept under conventional conditions in individ-
ually ventilated cages and fed normal chow diet. C57BL/6 (Envigo, Oxford, UK)
and Cx3cr1gfp+/gfp+ transgenic knockin mice (provided by Prof. Fiona Powrie,
University of Oxford) were used. Cx3cr1+/gfp+ mice were derived by breeding
Cx3cr1gfp+/gfp+ mice with outbred C57BL/6 mice (Envigo, Oxford, UK). Male
and female mice were infected or immunized when aged 6–8 weeks.
MCMV and Adenoviral Vector
The MCMV strain (Strain Smith; ATCC: VR194) was provided by Prof. U.H.
Koszinoswki (Max von Pettenkofer Institute). MCMV was propagated and
titrated on NIH 3T3 cells (European Collection of Authenticated Cell Cultures
[ECACC], Porton Down, UK), stored at 80C, and 2,000 or 1 3 106 PFU i.v.
injected. Replication-deficient recombinant adenovirus expressed the
b-galactosidase (b-gal) protein under the control of the HCMV promoter (Ad-
lacZ) (Bolinger et al., 2013). Ad-lacZ was propagated as previously described
(Bolinger et al., 2013; Lee et al., 2017).
Human Vaccination Protocols
The Ad6, ChAd3, and MVA vectors encoding the NS3-5B region of HCV
genotype 1B (NSmut) based on sequence accession number M58335, and
vaccination schedules have been described previously (Barnes et al., 2012;
Swadling et al., 2014) (NCT: NCT01070407 and NCT01296451). All volunteers
gave written informed consent before enrollment, and the studies were
conducted according to the principles of the Declaration of Helsinki and in
accordance with good clinical practice.(B) Individual CD8+ T cell subset distributions of CMV tetramer+ CD8+ T cells (n =
by a red cross.
(C) CX3CR1 subset frequency distributions of CMV tetramer+ CD8+ T cells.
(D) Composite FACS plots (n = 3) (L to R) of CD27, CD127, T-bet, and Eomes
expression for each CX3CR1 subset is indicated (n = 6).
(E) CMV tetramer+ CX3CR1 subsets expressing (L to R) CD27, CD127, T-bet, and
were determined by one-way ANOVA and corrected for multiple comparisons (
compiled from a single experiment.
(F) Hypothetical model for linear CD8+ T cell differentiation. CX3CR1 subsets ar
antigen exposure requirements. +, high expression; , no expression; +/, interDetection and Analysis of Virus and Vaccine-Specific T Cells
Tetramers and pentamers are shown in Table S3. Murine MHC class I mono-
mers complexed with M38 (H-2Kb), M45 (H-2Db), b-gal D8V (H-2Kb), and I8V
(H-2Kb) and some humanMHC class I monomers (A2-pp65, A1-pp50, andB7-
pp65) were tetramerized by addition of streptavidin-phycoerythrin (PE) (BD
Biosciences) or streptavidin-APC (Invitrogen). Peptide was obtained from
Proimmune (Oxford, UK). Aliquots of 100 mL of whole blood (mouse) or thawed
1 3 106 cells (human) were stained using a 50 mL solution of tetramers and
CX3CR1 antibody at 37C for 20 min followed by monoclonal antibody
(mAb) staining. Human pentamer (A2-NS3 and A2-pp65; Proimmune, Oxford,
UK) staining has been described previously (Swadling et al., 2014).
Flow Cytometry Analysis and In Vivo Antibody Labeling
Fluorochrome-conjugated antibodies are shown in Table S4. For in vivo anti-
body labeling, mice were injected i.v. with 3 mg fluorochrome-conjugated
anti-Thy1.2 (CD90.2) 10 min before tissue harvest, and lungs were perfused
with 15 mL PBS. For intranuclear staining, surface-stained cells were fixed,
washed, resuspended in permeabilization buffer (eBioscience FoxP3 staining
kit), and stained with anti-T-bet and Eomes antibodies. Cells were analyzed by
flow cytometry using a BD LSR II flow cytometer and FlowJo (Tree Star) and
gated on viable leukocytes using live/dead fixable near-infra-red (IR) (Invitro-
gen). Composite flow cytometer plots were generated by randomly selecting
equal numbers of each cell population of interest from each subject or from
all cells from each subject for populations with low cell number (i.e., pentamer+
cells).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (GraphPad, La Jolla,
CA). The p values for comparison of means were determined by two-tailed t
test and one-way and two-way ANOVA and were corrected using Holm-Sidak
for multiple comparisons.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and four tables and can be
found with this article online at https://doi.org/10.1016/j.celrep.2018.03.074.
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